|
|
|
Insider
Information: |
Tobin James R |
Relationship: |
|
City: |
Norwalk |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
696,846 |
|
Indirect Shares
|
209,696 |
|
|
Direct
Value |
$42,729,641 |
|
|
Indirect Value
|
$27,771,939 |
|
|
Total
Shares |
906,542 |
|
|
Total
Value |
$70,501,580 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
89.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Applera-Applied Biosys |
ABI |
Director |
2008-11-21 |
0 |
2003-09-02 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
President & CEO, Direc... |
2008-10-09 |
550,000 |
2008-10-09 |
16,550 |
Premium* |
|
Curis Inc |
CRIS |
Director |
2013-05-06 |
144,921 |
2007-06-06 |
0 |
Premium* |
|
Oxford Immunotec Global Plc |
OXFD |
|
2021-03-08 |
0 |
2020-06-24 |
0 |
Premium* |
|
Corindus Vascular Robotics, Inc. |
CVRS |
Director |
2019-10-29 |
0 |
2018-03-13 |
0 |
Premium* |
|
Transmedics Group, Inc. |
TMDX |
|
2024-05-23 |
1,925 |
2024-05-23 |
193,146 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CVRS |
Corindus Vascular Robotic... |
Director |
|
2019-10-29 |
4 |
D |
$4.28 |
$454,159 |
D/D |
(106,112) |
0 |
0 |
- |
|
OXFD |
Oxford Immunotec Global P... |
Director |
|
2020-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,081 |
4,081 |
0 |
- |
|
TMDX |
Transmedics Group, Inc. |
Director |
|
2021-02-09 |
4 |
AS |
$32.80 |
$333,786 |
I/I |
(10,168) |
424,637 |
0 |
% |
|
TMDX |
Transmedics Group, Inc. |
Director |
|
2021-12-15 |
4 |
GD |
$0.00 |
$0 |
I/I |
25,500 |
399,137 |
0 |
- |
|
TMDX |
Transmedics Group, Inc. |
Director |
|
2022-07-05 |
4 |
AS |
$35.00 |
$1,698,025 |
I/I |
(48,515) |
302,106 |
0 |
% |
|
TMDX |
Transmedics Group, Inc. |
Director |
|
2022-07-29 |
4 |
AS |
$39.98 |
$1,939,630 |
I/I |
(48,515) |
253,591 |
0 |
% |
|
TMDX |
Transmedics Group, Inc. |
Director |
|
2023-02-23 |
4 |
AS |
$75.13 |
$751,300 |
I/I |
(10,000) |
243,591 |
0 |
% |
|
ABI |
Applera-Applied Biosys |
officerTitle |
|
2005-12-01 |
4 |
A |
$12.39 |
$2,263 |
D/D |
183 |
6,048 |
|
- |
|
ABI |
Applera-Applied Biosys |
officerTitle |
|
2005-12-01 |
4 |
A |
$27.89 |
$12,737 |
D/D |
457 |
19,051 |
|
- |
|
ABI |
Applera-Applied Biosys |
officerTitle |
|
2007-03-01 |
4 |
A |
$13.70 |
$2,846 |
D/D |
208 |
7,949 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
officerTitle |
|
2007-03-01 |
4 |
A |
$30.32 |
$14,654 |
D/D |
483 |
23,914 |
0 |
- |
|
BSX |
Boston Scientific Corp |
President & CEO |
|
2004-07-29 |
4 |
OE |
$6.13 |
$306,250 |
D/D |
50,000 |
100,000 |
|
- |
|
BSX |
Boston Scientific Corp |
President & CEO |
|
2008-02-07 |
4 |
OE |
$6.13 |
$613,000 |
D/D |
100,000 |
200,000 |
0 |
- |
|
BSX |
Boston Scientific Corp |
President & CEO |
|
2008-10-09 |
4 |
OE |
$6.13 |
$2,145,500 |
D/D |
350,000 |
550,000 |
0 |
- |
|
BSX |
Boston Scientific Corp |
President and CEO |
|
2004-04-26 |
4 |
AS |
$41.81 |
$3,159,929 |
D/D |
(75,400) |
50,000 |
|
- |
|
BSX |
Boston Scientific Corp |
President and CEO |
|
2004-04-26 |
4 |
AS |
$41.34 |
$3,651,834 |
D/D |
(87,800) |
125,400 |
|
- |
|
BSX |
Boston Scientific Corp |
President and CEO |
|
2004-04-26 |
4 |
AS |
$41.05 |
$13,875,445 |
D/D |
(336,800) |
213,200 |
|
- |
|
BSX |
Boston Scientific Corp |
President and CEO |
|
2004-04-26 |
4 |
OE |
$6.13 |
$3,065,000 |
D/D |
500,000 |
550,000 |
|
- |
|
BSX |
Boston Scientific Corp |
President and CEO |
|
2004-04-27 |
4 |
AS |
$40.40 |
$5,663,632 |
D/D |
(139,100) |
50,000 |
|
- |
|
BSX |
Boston Scientific Corp |
President and CEO |
|
2004-04-27 |
4 |
OE |
$6.13 |
$3,065,000 |
D/D |
500,000 |
550,000 |
|
- |
|
BSX |
Boston Scientific Corp |
President and CEO |
|
2004-04-27 |
4 |
AS |
$40.00 |
$8,480,899 |
D/D |
(211,100) |
189,100 |
|
- |
|
BSX |
Boston Scientific Corp |
President and CEO |
|
2004-04-27 |
4 |
AS |
$39.81 |
$5,990,686 |
D/D |
(149,800) |
400,200 |
|
- |
|
97 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|